Horiba Pentra DX Nexus – Clinical Case Study: Myeloproliferative Syndrome
24 Mar 2014The Pentra DX Nexus is the high-throughput hematology analyzer from Horiba Medical. This state-of- the art analyzer uses 5 recognised measurement parameters for differentiation and quantification of hematopoietic populations. This case study is the eleventh in a series of twelve, and gives differential plots, parameter flags and morphological analysis of a patient with Myeloproliferative Syndrome.
Related Products
Request Quote for All Products
Pentra DX Nexus Hematology Analyzer
Horiba MedicalOverview Autoloader with continuous loading capability Rack compatibles with most pre and post analytical systems Automatic reflex testing Double DIFF Matrix Body fluids Expert validation station DHSS* technology (*HORIBA Medical Patent) Features Methods of measurement: flow cytometry, Cytochemistry, Impedance, absorbance, Optical cytometry and fluoro-flowcytometry QuaDimension concept : automatic correction of the leucocyte count based on 4 independent principles DHSS: focused flow cytometry and sequential measurement (impedance and absorbance) Automatic reflex testing: selective and programmable (hematology parameters, alarms and flags, demography) Rack rotation mixing of samples: smooth and efficient Quality: complete traceability for each run in compliance with the accreditation requirements